Reziciclideg

Reziciclideg is an orally active, potent dual CDK4 and CDK6 degrader with DC50 values ≤ 5 nM for both. Reziciclideg potently induces intracellular degradation of CDK4 and CDK6 proteins, blocks downstream RB protein phosphorylation (pRB Ser807/811), and inhibits the G1-to-S phase transition of the cell cycle, thereby suppressing tumor cell proliferation and overcoming CDK4/6 inhibitor resistance. Reziciclideg can be used for research on breast cancer.

For research use only. We do not sell to patients.

  • CAS No.: 3011828-23-9
  • Formula: C42H51N9O4
  • Molecular Weight:745.91
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Protocols
  • Purity & Documentation
  • References
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00